medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2020, Number 3

<< Back Next >>

Acta Ortop Mex 2020; 34 (3)

COVID-19 in orthopedics

Téllez-Duarte A, González-Ramírez LV

Language: Spanish
References: 25
Page: 153-157
PDF size: 133.00 Kb.


ABSTRACT

Study design: This is a systematic literature review for COVID-19, SARS-CoV-2 with Orthopedic and Spine Surgery relevance. Objectives: It is to determine in Orthopedic surgery and Spine Surgery and it’s branches the new required safety protocols when attending patients with risk of infection, or transmission for COVID-19 and comorbidities in the outpatient and inpatient hospital setting. Methods: A systematic literature review. Results: Recent knowledge for this disease has changed the Virus affects ORF-8 protein of the Hemoglobin destroying B-Hemoglobin, and IDC (intravascular disseminated coagulation) is found to happen in many patients, together with it’s capsular capability to adhere to metallic and plastic surfaces, pneumonic pattern associated with ventilator use, and the relapse in some patients, changes the view, preventative measures and treatment of this disease. Publication of global statistics show that patients with hypertension tend to have a higher rate of suffering the disease. Some new measures are proposed. Conclusions: New care guidelines for COVID-19 patients are proposed based on the new research on SARS-CoV-2 clinical pathologic findings are necessary.


REFERENCES

  1. Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382: 1564-7. doi: 10.1056/NEJMc2004973.

  2. Han Y, Král P. Computational design of ACE2-Based peptide inhibitors of SARS-CoV-2. ACS Nano. 2020; 14(4): 5143-7. doi: 10.1021/acsnano.0c02857.

  3. World Health Organization; Novel Coronavirus (2019-nCoV) situation. Report-1 21 January 2020; Available in: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4

  4. Xiaoxia Lu, Liqiong Zhang, Hui Du, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; doi: 10.1056/NEJMc2005073.

  5. Téllez DA, Gonzalez RL. COVID 19 in orthopedics; RG; Project: COVID-19. Research March 2020; doi: 10.13140/RG.2.2.24079.53925.

  6. Holshue ML. First Case of 2019 Novel coronavirus in the United States. N Engl J Med. 2020; 382: 929-36. doi: 10.1056/NEJMoa2001191.

  7. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020; 382: 1787-99. doi: 10.1056/NEJMoa2001282.

  8. Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, et al. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020; 40(5): 351-60. doi: 10.3343/alm.2020.40.5.351.

  9. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020; 8(4): E21. doi: https://doi.org/10.1016/PII.

  10. Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. 2020; doi: 10.1111/jth.14872.

  11. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020; 12(7): 6049-57. doi: 10.18632/aging.103000.

  12. Fisher D, Wilder-Smith A. The global community needs to swiftly ramp up the response to contain COVID-19. Lancet Respir Med. 2020, Available in: https://doi.org/10.1016/ S01406736(20)30679-6.

  13. World Health Organization; Coronavirus disease 2019 (COVID-19); Situation Report 58; March 18, 2020; doi: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200318-sitrep-58-covid-19.pdf?sfvrsn=20876712_2.

  14. Zhou F. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Respir Med. 2020; 395(10229): P1054-62. Available in: https://doi.org/10.1016/S0140-6736(20)30566-3.

  15. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020; 382: e101. doi: 10.1056/NEJMoa2007016.

  16. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020; 57: 279-83. pii: S0883-9441(20)30390-7. doi: 10.1016/j.jcrc.2020.03.005.

  17. Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020; 105938. doi: 10.1016/j.ijantimicag.2020.105938.

  18. Zimmerli W, Sendi P. Orthopaedic biofilm infections. APMIS. 2017; 125(4): 353-64. doi: 10.1111/apm.12687.

  19. Li Y, Hu Y, Yu Y, Zhang X, Li B, Wu J, et al. Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China. J Med Virol. 2020; doi: 10.1002/jmv.25905.

  20. Proceedings of the Frontiers of Retrovirology Conference 2016; Retrovirology. 2016; 13(Suppl 1): 68. Published online 2016; doi: 10.1186/s12977-016-0294-5.

  21. Loureiro A, da Silva GJ; CRISPR-Cas: converting a bacterial defence mechanism into a state-of-the-art genetic manipulation tool; antibiotics (Basel). 2019; 8(1): 18. Published online 2019 Feb 28. doi: 10.3390/antibiotics8010018.

  22. Decaroa N, Lorussob A. Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses. Vet Microbiol. 2020; 244: 108693. Published online 2020 Apr 14. doi: 10.1016/j.vetmic.2020.108693.

  23. Bachanova V, Bishop MR. Chimeric antigen receptor T cell therapy during the COVID-19 Pandemic. Biol Blood Marrow Transplant. 2020; 26(7): 1239-46. doi: 10.1016/j.bbmt.2020.04.008.

  24. Dhama K, Sharun K. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother. 2020; 1-7. Published online 2020 Mar 18. doi: 10.1080/21645515.2020.1735227.

  25. Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol. 2020; 38(1): 10-8. doi: 10.12932/AP-200220-0773.




2020     |     www.medigraphic.com